Back to Search Start Over

Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease

Authors :
Keller, M. F.
Saad, M.
Bras, J.
Bettella, F.
Nicolaou, N.
Simon-Sanchez, J.
Mittag, F.
Buchel, F.
Sharma, M.
Gibbs, J. R.
Schulte, C.
Moskvina, V.
Durr, A.
Holmans, P.
Kilarski, L. L.
Guerreiro, R.
Hernandez, D. G.
Brice, A.
Ylikotila, P.
Stefansson, H.
Majamaa, K.
Morris, H. R.
Williams, N.
Gasser, T.
Heutink, P.
Wood, N. W.
Hardy, J.
Martinez, M.
Jankowski, Janusz
Nalls, M. A.
Singleton, A. B.
Keller, M. F.
Saad, M.
Bras, J.
Bettella, F.
Nicolaou, N.
Simon-Sanchez, J.
Mittag, F.
Buchel, F.
Sharma, M.
Gibbs, J. R.
Schulte, C.
Moskvina, V.
Durr, A.
Holmans, P.
Kilarski, L. L.
Guerreiro, R.
Hernandez, D. G.
Brice, A.
Ylikotila, P.
Stefansson, H.
Majamaa, K.
Morris, H. R.
Williams, N.
Gasser, T.
Heutink, P.
Wood, N. W.
Hardy, J.
Martinez, M.
Jankowski, Janusz
Nalls, M. A.
Singleton, A. B.
Publication Year :
2012

Abstract

Genome-wide association studies (GWASs) have been successful at identifying single-nucleotide polymorphisms (SNPs) highly associated with common traits; however, a great deal of the heritable variation associated with common traits remains unaccounted for within the genome. Genome-wide complex trait analysis (GCTA) is a statistical method that applies a linear mixed model to estimate phenotypic variance of complex traits explained by genome-wide SNPs, including those not associated with the trait in a GWAS. We applied GCTA to 8 cohorts containing 7096 case and 19 455 control individuals of European ancestry in order to examine the missing heritability present in Parkinson's disease (PD). We meta-analyzed our initial results to produce robust heritability estimates for PD types across cohorts. Our results identify 27% (95% CI 17–38, P = 8.08E − 08) phenotypic variance associated with all types of PD, 15% (95% CI −0.2 to 33, P = 0.09) phenotypic variance associated with early-onset PD and 31% (95% CI 17–44, P = 1.34E − 05) phenotypic variance associated with late-onset PD. This is a substantial increase from the genetic variance identified by top GWAS hits alone (between 3 and 5%) and indicates there are substantially more risk loci to be identified. Our results suggest that although GWASs are a useful tool in identifying the most common variants associated with complex disease, a great deal of common variants of small effect remain to be discovered.

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn982697578
Document Type :
Electronic Resource